Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
10.01.25
/
50%
€10.22
Target price
10.01.26
€58.40
Performance (%)
-11.94%
End price
11.01.26
€9.00
Summary
This prediction ended on 11.01.26 with a price of €9.00. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.94%. Wells_Fargo___Compan has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.393% | -3.393% | 34.897% |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Wells Fargo & Company from $70.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
15.68%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.35
18.11.24
18.11.24
€66.07
18.11.25
18.11.25
-46.02%
19.11.25
19.11.25